Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma.
Jang YJ, Kim EJ, Kim HD, Kim KP, Ryu MH, Park SR, Choi WM, Lee D, Choi J, Shim JH, Kim KM, Lim YS, Lee HC, Ryoo BY, Yoo C.
Jang YJ, et al. Among authors: park sr.
J Cancer Res Clin Oncol. 2023 Aug;149(10):7547-7555. doi: 10.1007/s00432-023-04704-3. Epub 2023 Mar 27.
J Cancer Res Clin Oncol. 2023.
PMID: 36971796